Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 289

Similar articles for PubMed (Select 16415705)

1.

Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial.

Sepede G, De Berardis D, Gambi F, Campanella D, La Rovere R, D'Amico M, Cicconetti A, Penna L, Peca S, Carano A, Mancini E, Salerno RM, Ferro FM.

J Clin Psychopharmacol. 2006 Feb;26(1):45-9.

PMID:
16415705
2.

The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study.

Dannon PN, Iancu I, Grunhaus L.

Hum Psychopharmacol. 2002 Oct;17(7):329-33.

PMID:
12415550
3.

A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.

PMID:
18090457
4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
6.

Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.

Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM.

J Psychiatr Res. 2002 Jul-Aug;36(4):229-36.

PMID:
12191627
7.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
8.

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R.

Arch Gen Psychiatry. 1998 Nov;55(11):1010-6.

PMID:
9819070
9.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group.

J Clin Psychiatry. 2005 Jan;66(1):34-40.

PMID:
15669886
10.

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.

Am J Psychiatry. 1998 Jan;155(1):36-42.

PMID:
9433336
11.

An open-label trial of risperidone augmentation for refractory anxiety disorders.

Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH.

J Clin Psychiatry. 2006 Mar;67(3):381-5.

PMID:
16649823
12.

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J, Cohen M.

J Clin Psychiatry. 2001 Jun;62(6):413-20.

PMID:
11465517
13.
14.

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.

Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L.

J Clin Psychopharmacol. 2000 Oct;20(5):556-9.

PMID:
11001241
15.

Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.

Maina G, Vitalucci A, Gandolfo S, Bogetto F.

J Clin Psychiatry. 2002 Jan;63(1):38-43.

PMID:
11838624
16.

Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.

Sharpley AL, Attenburrow ME, Hafizi S, Cowen PJ.

J Clin Psychiatry. 2005 Apr;66(4):450-4.

PMID:
15816787
17.

The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.

Sheikh JI, Londborg P, Clary CM, Fayyad R.

Int Clin Psychopharmacol. 2000 Nov;15(6):335-42.

PMID:
11110009
18.

Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.

Pollack MH, Simon NM, Zalta AK, Worthington JJ, Hoge EA, Mick E, Kinrys G, Oppenheimer J.

Biol Psychiatry. 2006 Feb 1;59(3):211-5. Epub 2005 Sep 1.

PMID:
16139813
19.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk